scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Pasquale Assennato | |
Marco Caruso | |||
Eluisa La Franca | |||
Laura Ajello | |||
Angela Sansone | |||
Rosanna Iacona | |||
P2860 | cites work | 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration | Q22306346 |
Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial | Q28241346 | ||
Use of a continuous-flow device in patients awaiting heart transplantation | Q28244009 | ||
Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. | Q33272921 | ||
Cerebrovascular accidents in patients with a ventricular assist device. | Q33375726 | ||
Long-term use of a left ventricular assist device for end-stage heart failure. | Q34109624 | ||
Patient selection for the use of ventricular assist devices as a bridge to transplantation | Q35160130 | ||
Ventricular assist devices as destination therapy | Q35724585 | ||
Current status of cardiac transplantation and mechanical circulatory support | Q37407716 | ||
Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support | Q38505074 | ||
Taking heart--cardiac transplantation past, present, and future | Q40305657 | ||
Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device | Q44633832 | ||
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model | Q44660988 | ||
Left ventricular assist device as destination therapy: application of the payment-by-results approach for the device reimbursement | Q46071421 | ||
Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). | Q48305783 | ||
Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. | Q48310222 | ||
Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. | Q50914359 | ||
On the fledgling field of mechanical circulatory support. | Q50931863 | ||
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. | Q50954069 | ||
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. | Q51010198 | ||
Improved mechanical reliability of the HeartMate XVE left ventricular assist system. | Q51129638 | ||
Six years of continuous mechanical circulatory support. | Q51158828 | ||
The Fourth INTERMACS Annual Report: 4,000 implants and counting. | Q51178030 | ||
Mechanical and biologic analysis of a 1,512-day-long implanted Novacor left ventricular assist device. | Q51241265 | ||
Patients supported for over 4 years with left ventricular assist devices. | Q51242171 | ||
Left ventricular assist devices as destination therapy: a new look at survival. | Q51558476 | ||
More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure | Q57396381 | ||
Patient selection for left ventricular assist devices | Q62770373 | ||
Case report: circulatory support for seventy days with resolution of acute heart failure | Q68072830 | ||
Improved Mortality and Rehabilitation of Transplant Candidates Treated with a Long-Term Implantable Left Ventricular Assist System | Q72065584 | ||
The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000 | Q73109430 | ||
Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome | Q73513246 | ||
Heart failure: how big is the problem? Who are the patients? What does the future hold? | Q73637348 | ||
Intracranial bleed during bridge to transplant may not preclude a successful result | Q74363611 | ||
Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure | Q77614535 | ||
Heart failure--an epidemic of uncertain proportions | Q78455644 | ||
[Consensus conference on the management of heart failure] | Q80131297 | ||
[Mechanical assist devices in advanced heart failure. Indications and perspectives] | Q82803560 | ||
Intractable cardiogenic shock in stress cardiomyopathy with left ventricular outflow tract obstruction: is extra-corporeal life support the best treatment? | Q83904006 | ||
[Actual role of cardiocirculatory assistance in heart failure treatment] | Q84410477 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heart failure | Q181754 |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 11-19 | |
P577 | publication date | 2013-05-14 | |
P1433 | published in | Global Journal of Health Science | Q23979247 |
P1476 | title | Heart failure and mechanical circulatory assist devices | |
P478 | volume | 5 |
Search more.